Repligen Corp reports results for the quarter ended in December - Earnings Summary

Repligen

21/02/2024 15:01

* Repligen Corp  RGEN.OQ  reported quarterly adjusted
earnings of
33 cents​​ per share for the quarter ended in December, lower
than the same quarter last year, when the company reported EPS
of 68 cents.  The mean expectation of twelve analysts for the
quarter was for earnings of 33 cents per share. Wall Street
expected results to range from 30 cents to 35 cents per share.
    * Revenue fell 16.6% to $155.74 million from a year ago;
analysts
expected $155.39 million. 
    * Repligen Corp's reported EPS for the quarter was a loss
of 46
cents​.
    * The company reported a quarterly loss of $25.49 million.
    * Repligen Corp shares had risen by 11.1% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Repligen Corp is
$192.50 
This summary was machine generated from LSEG data February 21 at
03:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.33           0.33           Met
 Sep. 30 2023      0.17           0.23           Beat
 Jun. 30 2023      0.48           0.53           Beat
 Mar. 31 2023      0.59           0.64           Beat